Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Lung Cancer Survival in Lithuania: Changes by Histology, Age, and Sex From 2003-2007 to 2008-2012.

Gedvilaitė V, Danila E, Cicėnas S, Smailytė G.

Cancer Control. 2019 Jan-Dec;26(1):1073274819836085. doi: 10.1177/1073274819836085.

2.

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.

Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators.

Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4.

PMID:
30955977
3.

Suicide risk among lung cancer patients in Lithuania.

Kaceniene A, Danila E, Cicenas S, Smailyte G.

Clin Respir J. 2018 Sep;12(9):2455-2456. doi: 10.1111/crj.12916. Epub 2018 Aug 29. No abstract available.

PMID:
30073786
4.

Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer.

Stumbryte A, Gudleviciene Z, Kundrotas G, Dabkeviciene D, Kunickaite A, Cicenas S.

Oncotarget. 2017 Nov 29;9(3):3214-3229. doi: 10.18632/oncotarget.22756. eCollection 2018 Jan 9.

5.

Sternal resection of a solitary renal cell carcinoma metastasis: a case report and a literature review.

Čerškutė M, Kinčius M, Januškevičius T, Cicėnas S, Ulys A.

Acta Med Litu. 2018;25(4):226-233. doi: 10.6001/actamedica.v25i4.3933.

6.

Cell-free DNA in non-small cell lung cancer.

Gedvilaitė V, Schveigert D, Cicėnas S.

Acta Med Litu. 2017;24(2):138-144. doi: 10.6001/actamedica.v24i2.3495.

7.

Non-pulmonary cancer risk following tuberculosis: a nationwide retrospective cohort study in Lithuania.

Everatt R, Kuzmickiene I, Davidaviciene E, Cicenas S.

Infect Agent Cancer. 2017 May 31;12:33. doi: 10.1186/s13027-017-0143-8. eCollection 2017.

8.

Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study).

Cicènas S, Geater SL, Petrov P, Hotko Y, Hooper G, Xia F, Mudie N, Wu YL.

Lung Cancer. 2016 Dec;102:30-37. doi: 10.1016/j.lungcan.2016.10.007. Epub 2016 Oct 20.

9.

CD8(high)CD57(+) T-cell population as an independent predictor of response to chemoradiation therapy in extensive-stage small cell lung cancer.

Dobrovolskienė NT, Cicėnas S, Kazlauskaitė N, Mišeikytė-Kaubrienė E, Krasko JA, Ostapenko V, Pašukonienė V, Strioga MM.

Lung Cancer. 2015 Nov;90(2):326-33. doi: 10.1016/j.lungcan.2015.08.001. Epub 2015 Aug 4.

PMID:
26319316
10.

Prevalence of human papillomaviruses in patients with head and neck squamous cell carcinoma in Lithuania and Belarus.

Gudleviciene Z, Didziapetriene J, Mackeviciene I, Cicenas S, Smolyakova R, Zhukavetc A.

J Med Virol. 2014 Mar;86(3):531-5. doi: 10.1002/jmv.23750. Epub 2013 Sep 16. Erratum in: J Med Virol. 2014 Jul;86(7):1279. Zivile, Gudleviciene [corrected to Gudleviciene, Zivile]; Janina, Didziapetriene [corrected to Didziapetriene, Janina]; Irina, Mackeviciene [corrected to Mackeviciene, Irina]; Saulius, Cicenas [corrected to Cicenas, Saulius]; Raisa, Smolyakova [corrected t.

PMID:
24105830
11.

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.

Ciuleanu T, Stelmakh L, Cicenas S, Miliauskas S, Grigorescu AC, Hillenbach C, Johannsdottir HK, Klughammer B, Gonzalez EE.

Lancet Oncol. 2012 Mar;13(3):300-8. doi: 10.1016/S1470-2045(11)70385-0. Epub 2012 Jan 24.

PMID:
22277837
12.

Extralobar pulmonary sequestration.

Ulys A, Samalavicius NE, Cicenas S, Petraitis T, Trakymas M, Sheinin D, Gatijatullin L.

Int Med Case Rep J. 2011 Apr 1;4:21-3. doi: 10.2147/IMCRJ.S15261. Print 2011.

13.

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.

Cappuzzo F, Ciuleanu T, Stelmakh L, Cicenas S, Szczésna A, Juhász E, Esteban E, Molinier O, Brugger W, Melezínek I, Klingelschmitt G, Klughammer B, Giaccone G; SATURN investigators.

Lancet Oncol. 2010 Jun;11(6):521-9. doi: 10.1016/S1470-2045(10)70112-1. Epub 2010 May 20.

PMID:
20493771
14.

[Treatment outcome of locally advanced stage IIIA/B lung cancer].

Cicenas S, Zaliene A, Atkocius V.

Medicina (Kaunas). 2009;45(6):452-9. Lithuanian.

15.

Spontaneous pneumothorax as a first sign of pulmonary carcinoma.

Vencevicius V, Cicenas S.

World J Surg Oncol. 2009 Jun 30;7:57. doi: 10.1186/1477-7819-7-57.

16.

[Malignant pleural diseases: diagnosis and treatment].

Cicenas S, Vencevicius V.

Medicina (Kaunas). 2008;44(12):929-35. Lithuanian.

17.

Occupational asbestos exposure among respiratory cancer patients in Lithuania.

Everatt RP, Smolianskiene G, Tossavainen A, Cicenas S, Jankauskas R.

Am J Ind Med. 2007 Jun;50(6):455-63.

PMID:
17497698
18.

Lung cancer in patients with tuberculosis.

Cicenas S, Vencevicius V.

World J Surg Oncol. 2007 Feb 19;5:22.

19.

Trends in laryngeal cancer incidence in Lithuania: a future perspective.

Jaseviciene L, Gurevicius R, Obelenis V, Cicenas S, Juozulynas A.

Int J Occup Med Environ Health. 2004;17(4):473-7.

PMID:
15852762
20.

[Hypotensive epidural anesthesia in thoracic surgery].

Tikuisis R, Miliauskas P, Zurauskas A, Cicenas S, Eidukevicius R, Jackevicius A.

Medicina (Kaunas). 2004;40(12):1189-96. Lithuanian.

Supplemental Content

Loading ...
Support Center